Practical enantiospecific synthesis of RPR 111905: A novel non-peptide substance P antagonist

被引：10

作者：

Mutti, S

Daubie, C

Malpart, J

Radisson, X

机构：

[1] Rhone-Poulenc Rorer - Ctr. de R., Chemical Process - 13, Quai Jules Guesde, 94403 Vitry sur Seine

来源：

TETRAHEDRON LETTERS | 1996年 / 37卷 / 48期

关键词：

D O I：

10.1016/S0040-4039(96)02017-5

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

The synthesis of enantiomerically pure RPR 111905 was achieved in twelve steps with an overall yield of 6.9%. The synthetic strategy was based on a Diels-Alder reaction to generate the bicyclic framework and the asymmetry was introduced by resolution. Copyright (C) 1996 Elsevier Science Ltd

引用

页码：8743 / 8746

页数：4

共 50 条

[41] Design, synthesis and binding affinities of novel non-peptide mimics of somatostatin/sandostatin(R)
Damour, D
Barreau, M
Blanchard, JC
Burgevin, MC
Doble, A
Herman, F
Pantel, G
JamesSurcouf, E
Vuilhorgne, M
Mignani, S
Poitout, L
LeMerrer, Y
Depezay, JC
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (14) : 1667 - 1672
[42] Synthesis of non-peptide drug candidates that antagonize the peptide hormone cholecystokinin
DiPardo, RM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 202 - ORGN
[43] The design and synthesis of non-peptide somatostatin receptor agonists
Yang, LH
Pan, YP
Guo, LQ
Morriello, G
Pasternak, A
Rohrer, S
Schaeffer, J
Patchett, AA
PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 250 - 252
[44] Dynamic effects of a novel, non-peptide ADH (V2) antagonist in cirrhotic patients with ascites.
Guyader, D
Ellis-Grosse, EJ
Burke, JT
Orczyk, GP
HEPATOLOGY, 1998, 28 (04) : 559A - 559A
[45] A low molecular weight non-peptide antagonist of glucagon-like peptide-1
Grönberg, A
Sol, ER
Danielsson, A
Colca, JR
Bergsten, P
DIABETES, 2000, 49 : A251 - A251
[46] Pharmacokinetic and pharmaeodynamic analysis of a novel (Oral) non-peptide oxytocin antagonist in non-pregnant and pregnant rhesus monkeys.
Grigsby, P. L.
Rasanen, J. P.
Sadowsky, D. W.
Bertolino, M.
Carbonatto, M.
Tos, E. Gillio
Canali, S.
Lacy, J.
Chollet, A.
Novy, M. J.
REPRODUCTIVE SCIENCES, 2008, 15 (02) : 111A - 112A
[47] Multivalency of non-peptide integrin αvβ3 antagonist slows tumor growth
Kim, Yoo-Shin
Li, Feng
O'neill, Brian E.
Li, King C. P.
Li, Zheng
CANCER RESEARCH, 2012, 72
[48] Discovery of a potent, non-peptide bradykinin B1 receptor antagonist
Su, DS
Markowitz, MK
DiPardo, RM
Murphy, KL
Harrell, CM
O'Malley, SS
Ransom, RW
Chang, RSL
Ha, S
Hess, FJ
Pettibone, DJ
Mason, GS
Boyce, S
Freidinger, RM
Bock, MG
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (25) : 7516 - 7517
[49] Multivalency of Non-Peptide Integrin αVβ3 Antagonist Slows Tumor Growth
Kim, Yoo-Shin
Li, Feng
Kong, Ren
Bai, Yang
Li, King C. P.
Fan, Yubo
O'Neill, Brian E.
Li, Zheng
MOLECULAR PHARMACEUTICS, 2013, 10 (10) : 3603 - 3611
[50] Development of non-peptide antagonist ligands acting for CRF1 receptors
Grigoriadis, DE
Chen, C
Lorang, MT
Wilcoxen, K
Liu, XJ
Ling, N
BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 63S - 63S

← 1 2 3 4 5 →